TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03738410

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile Health Messaging application
Description: Mobile messaging sent to participants over a 12-month period.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care Treatment
Description: Standard of care (SOC) is defined as the usual care a licensed health care provider would give patients to treat HIV/AIDS. SOC associated procedures and policies may vary across clinical settings.
Study: NCT05277922

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Nitroprusside
Description: Ascending doses of 4, 8 and 16 µg
Study: NCT05992649

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: physical therapy
Description: Aquatic physiotherapy in warm water
Study: NCT03738410

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of Care Treatment
Description: Standard of care (SOC) is defined as the usual care a licensed health care provider would give patients to treat HIV/AIDS. SOC associated procedures and policies may vary across clinical settings.
Study: NCT06322810

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Description: Bilateral ESP: 0.5% ropivacaine 0.3 ml per kg (ideal body weight) each side, 30 min before skin excision. After surgery, use pump to deliver an intermittent automatic bolus of 0.3 ml per kg 0.16% ropivacaine every 4 hours each side.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pecto-intercostal fascial plane blok (PIFB)
Description: Bilateral PIFB: 0.5% ropivacaine 0.3 ml per kg (ideal body weight) each side, 30 min before skin excision. After surgery, use pump to deliver an intermittent automatic bolus of 0.3 ml per kg 0.16% ropivacaine every 4 hours each side.
Study: NCT04528303

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Whole genome sequencing
Description: Genomic sequencing and molecular diagnostic results

Intervention type: GENETIC
Group type: ACTIVE_COMPARATOR
Intervention: Whole exome sequencing
Description: Genomic sequencing and molecular diagnostic results
Study: NCT06290700

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neonatal Care education
Description: Participants who met the study inclusion criteria were provided with information about the purpose and conduct of the study, and their consent to participate was then obtained. The interviews were conducted in the breastfeeding room at the Uşak Dikilitaş Family Health Centre. The data were collected between November 2022 and November 2023. The Family Health Centre has two vaccination rooms, two antenatal care rooms, two observation rooms, and two breastfeeding rooms. Each pregnant woman was individually enrolled in an education session held in the breastfeeding room. The breastfeeding room was approximately 20 m², which was considered standard for accommodating training for an average of three pregnant women. The breastfeeding room was quiet, had a suitable temperature, and was located on the first floor in the middle of the corridor.
Study: NCT05826249

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIM0417/Ritonavir
Description: Single oral dose of 750 mg SIM0417 coadministered with 100 mg ritonavir.
Study: NCT05297071

Intervention type: DEVICE
Group type: OTHER
Intervention: Orascopic HDL 3.0 Loupes
Description: The loupes will be used during the surgical procedure on half of the subjects. The other half will be performed with a microscope.

Intervention type: DEVICE
Group type: OTHER
Intervention: Semorr DOM3000D Operation Microscope
Description: The microscope will be used during the surgical procedure on half of the subjects. The other half will be performed with loupes.
Study: NCT06186167

Intervention type: PROCEDURE
Intervention: Chest Wall Fat Tissue Collection
Description: As part of routine cardiac device implantation, chest wall fat tissue is collected for histopathological analysis. This tissue, which is typically discarded, will be used to identify amyloid deposits in high-risk cardiac patients. No additional surgical intervention is performed beyond the standard procedure for device implantation.
Study: NCT04722965

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fistulotomy with marsupialization
Description: A probe is placed in the fistula tract and it's laid open over that probe. The tract is curretted. Wound edges are sutured to the bottom of the fistula using interrupted sutures of vicryl 3-0 completing the marsupialization.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fistulotomy with open wound
Description: A probe is placed in the fistula tract and it's laid open over that probe. The tract is curretted. The wound is left open.
Study: NCT06315218

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iTHRIVE 365 HIV care intervention
Description: iTHRIVE 365 is a multicomponent intervention that combines mHealth features and institutional to support community priorities identified in formative CBPR. In line with best-practices for trials of intervention principles (TIPs) with mHealth interventions, iTHRIVE 365 deploys intervention elements that serve to accomplish intervention strategies. iTHRIVE 365 intervention strategies are to promote: 1)Health knowledge and motivation; 2)Social support coping; 3)Access to culturally-affirming healthcare; and 4)Housing and other economic resources. iTHRIVE 365 pursues these strategies via these intervention elements: 1)Weekly HIV and psychological health information and motivation content and daily health notifications; 2)Online moderated forums, interpersonal chats, and community calendars; 3)Linkage to biopsychosocial healthcare via THRIVE SS's network of Black SGLM-affirming providers; and 4)Housing and economic resources through THRIVE SS's direct support and referral network.
Study: NCT02315157

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: Given IV
Study: NCT05684965

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XTX301
Description: XTX301 monotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XTX301
Description: XTX301 monotherapy
Study: NCT05851404

Intervention type: PROCEDURE
Intervention: Thyroidectomy
Description: Total thyroidectomy or lobectomy

Intervention type: PROCEDURE
Intervention: Thyroidectomy
Description: Total thyroidectomy or lobectomy

Intervention type: PROCEDURE
Intervention: Thyroidectomy
Description: Total thyroidectomy or lobectomy

Intervention type: PROCEDURE
Intervention: Thyroidectomy
Description: Total thyroidectomy or lobectomy

Intervention type: PROCEDURE
Intervention: Thyroidectomy
Description: Total thyroidectomy or lobectomy
Study: NCT04788667

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: A health education programme using a telerehabilitation platform
Description: All patients enrolled in the study will receive information through the tele rehabilitation platform, although the experimental group will have specific training/education whereas the control group will only receive some general recommendations as control/sham

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: A health education programme using a telerehabilitation platform
Description: All patients enrolled in the study will receive information through the tele rehabilitation platform, although the experimental group will have specific training/education whereas the control group will only receive some general recommendations as control/sham
Study: NCT05680025

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical exercise intervention
Description: The intervention group will have access to training videos through social networks (WhatsApp and YouTube) and infographics. The mobile phone of each of the participants will allow send dates of workshops, link for videos, messages reminding to perform exercise routines.~The training plan will be designed so the participants will achieve being physically active at the end of 6 months of intervention. Training will be planned to gradually, through 3 levels, increase the duration and intensity of exercises; they will have an important component of aerobic exercises and others for muscular strength. Each level of training will last two months; at each level the participants will be given 4 specific trainings and will be asked to perform two per week at level 1 and 2; and at the 3 level, 3 trainings per week.~The strategy for promoting physical exercise is based on the social cognitive theory, in which the bases of the transtheoretical model are found.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Workshops
Description: Six workshops to promote the performance of physical activity. The workshops will be held with groups of 15 participants. During them, the work will be to promote motivation to perform physical exercise, sharing information about the health benefits, benefits for control of the disease, together creating planning of measurable, realistic goals; reinforcing behavior when the desired advances are made, monitoring progress (using a monthly self-report of exercise performed). The participants will be motivated and congratulated each time for goals reached, self-sufficiency will be reinforced as well as greater evaluation of the advantages of performing exercise against the barriers or negative aspects perceived by the participants. These activities will be performed according to the level of exercise performed by the individuals (stage of change).
Study: NCT04837482

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGN-190584
Description: Topical eyedrop

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGN-190584
Description: Topical eyedrop

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vehicle
Description: Topical eyedrop

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vehicle
Description: Topical eyedrop
Study: NCT05237622

Intervention type: DEVICE
Group type: OTHER
Intervention: High Flow
Description: Standard HighFlow therapy after weaning from continuous positive airway pressure therapy will be applied on different flow levels. Starting with a flow level of 8l/min, the flow-rates will be changed every 30 minutes subsequently from 8-6-4-2-4-6-8 l/min. Meanwhile, data on lung volume changes will be measured using electrical impedance tomography.
Study: NCT06030726

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Economic Principles
Description: The control arm will receive no letter to reflect the background vaccination uptake. Intervention arms will test the effects of different letters developed using behavioral economic principles.
Study: NCT05755594

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Robot-assisted Pancreaticoduodenectomy
Description: By performing pancreaticoduodenectomy on the subject using the latest generation Da Vinci robotic surgical system and assisted by another surgeon for the entire procedure
Study: NCT05616611

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: High-Intensity laser
Description: intervention that lasted 3 sessions/week for 12 weeks).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional physiotherapy exercises
Description: intervention that lasted 3 sessions/week for 12 weeks).

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Shock Wave therapy
Description: intervention that lasted 3 sessions/week for 12 weeks).
Study: NCT05183100

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tibial Nerve Neurodynamics
Description: The patient will lie supine with the trunk and neck in neutral position. During the first stage, participants will receive passive straight leg raise of the affected side held for 20 seconds for 3 repetitions. In the second stage, hip adduction and internal rotation, ankle dorsiflexion, and ankle eversion are added in the straight leg raise position. Slow oscillations of the ankle movement for 1 minute will be applied, followed by holding the position for 20 seconds, for 3 repetitions. In the third stage, the head of the patient will be held in flexion with pillows while the same oscillation procedure as the second stage is performed. There will be a 2-minute rest between the stages.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lying in supine
Description: Lying in supine position for about 13 minutes.
Study: NCT06455189

Intervention type: OTHER
Group type: OTHER
Intervention: Control Group - Standard of care neurosurgical resection
Description: The control group will include only standard of care tools. - Standard of care neurosurgical resection will include the use of all standard neurosurgical instruments and techniques (eg, microscope, intraoperative ultrasound, 5-ALA fluorescence guided surgery and neuronavigation system).

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MRF/MRI infiltration guidance for extended resection
Description: Magnetic resonance imaging, MRI, is a procedure that uses radio waves, a powerful magnet, and a computer to make a series of detailed pictures of areas inside the body
Study: NCT05919459

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 5-week online synchronous ACT intervention
Description: Parents will meet a trained ACT counsellor to undergo five weekly sessions of ACT group training via Zoom. Specifically, each 120-minute synchronous videoconferencing session will involve the ACT counsellor and 6-8 parents.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: asynchronous online AIS education
Description: A healthcare educator with a background in nursing, physiotherapy, or occupational therapy will meet with parents in five weekly 120-minute interactive AIS-related education videoconferencing via Zoom. Specifically, each 120-minute synchronous videoconferencing session will involve the ACT counsellor and 6-8 parents.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: asynchronous online AIS education
Description: A healthcare educator with a background in nursing, physiotherapy, or occupational therapy will meet with parents in five weekly 120-minute interactive AIS-related education videoconferencing via Zoom. Specifically, each 120-minute synchronous videoconferencing session will involve the ACT counsellor and 6-8 parents.
Study: NCT06338683

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olanzapine 2.5 MG
Description: Oral olanzapine 2.5 mg once daily at bedtime until disease progression

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard anti-tumor treatment
Description: Clinicians choose the appropriate standard antitumor drug therapy based on the patient's specific situation

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Standard anti-tumor treatment
Description: Clinicians choose the appropriate standard antitumor drug therapy based on the patient's specific situation

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nutritional advice
Description: All patients enrolled in the study were required to undergo a nutritional assessment and were provided with nutritional advice based on their condition

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Nutritional advice
Description: All patients enrolled in the study were required to undergo a nutritional assessment and were provided with nutritional advice based on their condition
Study: NCT06173895

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3454738
Description: Administered subcutaneously (SC)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3454738
Description: Administered subcutaneously (SC)
Study: NCT03843437

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tencel Therapeutic Garments
Description: Children age 6 months to 3 years will wear a Tencel full body suit with feet and mittens, while children age 3-6 years will wear Tencel long-sleeve shirts and pants that do not cover the hands and feet. Children will wear the study garments at night but may also wear garments during the day if desired.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Cotton Therapeutic Garments
Description: Children age 6 months to 3 years will wear a cotton full body suit with feet and mittens, while children age 3-6 years will wear cotton long-sleeve shirts and pants that do not cover the hands and feet. Children will wear the study garments at night but may also wear garments during the day if desired.
Study: NCT06030726

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Economic Principles
Description: The control arm will receive no letter to reflect the background vaccination uptake. Intervention arms will test the effects of different letters developed using behavioral economic principles.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Economic Principles
Description: The control arm will receive no letter to reflect the background vaccination uptake. Intervention arms will test the effects of different letters developed using behavioral economic principles.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Economic Principles
Description: The control arm will receive no letter to reflect the background vaccination uptake. Intervention arms will test the effects of different letters developed using behavioral economic principles.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Economic Principles
Description: The control arm will receive no letter to reflect the background vaccination uptake. Intervention arms will test the effects of different letters developed using behavioral economic principles.
Study: NCT05739747

Intervention type: OTHER
Intervention: Questionnaire
Description: All patients should complete the following questionnaires:~On the day of surgery:~* Patient registration.~* Complete medical history.~* Gendolcat scale (including the Spanish version of the SF-12 scale).~* Spanish version of the catastrophizing scale.

Intervention type: OTHER
Intervention: Questionnaire
Description: The investigators should complete a questionnaire during the surgical procedure specifying the anesthetic technique used, drugs and doses used and record any incident during the surgical procedure

Intervention type: OTHER
Intervention: Questionnaire
Description: The investigators should complete a questionnaire 24 hours after surgery to assess the possible presence of postoperative pain as well as the intensity and need for rescue analgesia.

Intervention type: OTHER
Intervention: Questionnaire via telephone call
Description: At 3 months, patients will be called and a structured questionnaire will be completed to assess the presence of chronic postoperative pain.

Intervention type: OTHER
Intervention: Physical examination
Description: Those women who, after the telephone call, are considered to have chronic post-surgical pain will undergo a physical examination to confirm it. The type of pain and its intensity will also be evaluated. The impact on their daily physical activity and quality of life will be evaluated by means of a questionnaire.
Study: NCT05934344

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Action observation training
Description: The activities proposed will be based on items from the FMA scale (Voluntary movement within synergies, voluntary movement mixing synergies, voluntary movement with little or no synergy, grip, coordination/speed, passive joint movement), and the exercises for the lower limbs will be designed by the authors of the study, based on Vivifrail (32), a multicomponent physical training program for the prevention of deconditioning and falls in older adults. These exercises will be progressive each week, focusing on strengthening, balance, and functional exercises to improve gait. The sessions will last between 20 and 30 minutes, with a frequency of three days per week. The intervention will last for 5 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Action observation training
Description: The activities proposed will be based on items from the FMA scale (Voluntary movement within synergies, voluntary movement mixing synergies, voluntary movement with little or no synergy, grip, coordination/speed, passive joint movement), and the exercises for the lower limbs will be designed by the authors of the study, based on Vivifrail (32), a multicomponent physical training program for the prevention of deconditioning and falls in older adults. These exercises will be progressive each week, focusing on strengthening, balance, and functional exercises to improve gait. The sessions will last between 20 and 30 minutes, with a frequency of three days per week. The intervention will last for 5 weeks.
Study: NCT06114823

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: carpal tunnel release mini-incision
Description: Patients were subjected to a longitudinal mini-incision started just above the proximal flexor wrist crease and then extended for 1.5 - 2 cm in a proximal direction

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: carpal tunnel release mini-incision
Description: Patients were subjected to a longitudinal mini-incision started just above the proximal flexor wrist crease and then extended for 1.5 - 2 cm in a proximal direction

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: carpal tunnel release conventional incision
Description: Patients were subjected a longitudinal incision which was created between the thenar and hypothenar eminences along the longitudinal axis of the ring finger. Then, it was extended to the proximal flexor wrist crease.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: carpal tunnel release conventional incision
Description: Patients were subjected a longitudinal incision which was created between the thenar and hypothenar eminences along the longitudinal axis of the ring finger. Then, it was extended to the proximal flexor wrist crease.
Study: NCT05181137

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR0302
Description: Oral tablets taken once daily (QD)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR0302
Description: Oral tablets taken once daily (QD)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR0302
Description: Oral tablets taken once daily (QD)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral tablets taken once daily (QD)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral tablets taken once daily (QD)
Study: NCT06325982

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triethanolamine cream
Description: Triethanolamine cream retention enema was given once every night before going to bed during radiotherapy until the end of radiotherapy. Triethanolamine cream retention enema was given once before going to bed the day after radiotherapy for 3 months.~Preparation method: Pull out the syringe piston, add 15ml triethanolamine cream, add 30ml normal saline, gently pat, shake well.~Specific methods of retention enema: at night before going to bed, empty urine and feces, prepare enema liquid into the syringe, connect the special catheter, and insert the other end of the special catheter into the anus (the special catheter can be applied with lubricant such as tea oil before insertion). The patient remained prone and semi-seated. Use a special catheter, insert a special catheter about 15cm from the anus, and inject enteral liquid while withdrawing, so that the liquid is retained in the rectum; The above treatment was performed before bed and retained overnight.